These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 577334)

  • 1. Reversible plasma and red blood cells volumes increases in acromegaly.
    Strauch G; Lego A; Therain F; Bricaire H
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):465-78. PubMed ID: 577334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
    Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
    J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular volumes evaluated by a carbon monoxide rebreathing method in patients undergoing chronic hemodialysis.
    Bomholt T; Larsson S; Rix M; Rytter S; Feldt-Rasmussen B; Hornum M; Lundby C
    Hemodial Int; 2020 Apr; 24(2):252-260. PubMed ID: 32052563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.
    Christ ER; Cummings MH; Westwood NB; Sawyer BM; Pearson TC; Sönksen PH; Russell-Jones DL
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2985-90. PubMed ID: 9284731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion.
    Barkan AL; Beitins IZ; Kelch RP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):69-73. PubMed ID: 2897974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin decreases circulating growth hormone levels in acromegaly.
    Giustina A; Bodini C; Doga M; Schettino M; Pizzocolo G; Giustina G
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1296-300. PubMed ID: 1375598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell volume is not decreased in ESA-naive anemic chronic kidney disease patients.
    Lundby C; Ponte B; Lundby AK; Robach P; de Seigneux S
    Physiol Rep; 2018 Nov; 6(21):e13900. PubMed ID: 30426716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of growth hormone (GH) plasma clearance rate, half-life, and volume of distribution in acromegalic patients: the combined GH-octreotide infusion.
    Lanzi R; Andreotti AC; Caumo A; Manzoni MF; Losa M; Malighetti ME; Pontiroli AE
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3279-83. PubMed ID: 7593438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
    Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
    Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone and insulin-like growth factor I on urinary albumin excretion: studies in acromegaly and growth hormone deficiency.
    Hoogenberg K; Sluiter WJ; Dullaart RP
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):151-7. PubMed ID: 8372600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of acromegaly by measurement of 24-hourly urinary growth hormone excretion.
    Pholséna M; Le Bouc Y; Rousseau E; Christol R; Birman P; Périn L; Girard F
    Acta Endocrinol (Copenh); 1993 Jan; 128(1):9-14. PubMed ID: 8447199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH.
    Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly.
    Chihara K; Kaji H; Minamitani N; Kodama H; Kita T; Goto B; Chiba T; Coy DH; Fujita T
    J Clin Endocrinol Metab; 1984 Jan; 58(1):81-6. PubMed ID: 6417157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide.
    Morange I; De Boisvilliers F; Chanson P; Lucas B; DeWailly D; Catus F; Thomas F; Jaquet P
    J Clin Endocrinol Metab; 1994 Jul; 79(1):145-51. PubMed ID: 8027218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma.
    Gorden P; Lesniak MA; Eastman R; Hendricks CM; Roth J
    J Clin Endocrinol Metab; 1976 Aug; 43(2):364-73. PubMed ID: 950368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.